Design and validation of a semi-quantitative microneutralization assay for human Metapneumovirus A1 and B1 subtypes

Since 2001, human Metapneumovirus has been a significant cause of human respiratory disease worldwide, and no vaccine or preventive treatment is currently available. The ELISA-based live virus microneutralization assay is a method to detect neutralizing antibodies against a target pathogen. The aim of this study was to demonstrate the suitability of this approach to quantifying neutralizing antibodies against A1 and B1 virus subtypes in human serum samples. To standardize and validate this microneutralization assay, we carried out analytical procedures according to the International Council of Harmonization guidelines; these procedures are described in detail. In addition, we compared the validated method with the indirect ELISA, and confirmed that the ELISA-based microneutralization assay provides reliable, accurate and reproducible results. The use of this high-throughput method for large-scale serological studies could effectively support the evaluation of the immunogenicity of new vaccines, thereby improving therapeutical strategies against human Metapneumovirus.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-04-04
DOI
https://doi.org/10.1038/s41598-025-96567-6
Citations
2
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
2.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design and validation of a semi-quantitative microneutralization assay for human Metapneumovirus A1 and B1 subtypes

Angela Stufano, Mariangela Pizzo, Simona De Grazia, Francesca Dapporto et al.
2 citations
Scientific Reports
Respiratory viral infections research
2.71
article

Design and validation of a semi-quantitative microneutralization assay for human Metapneumovirus A1 and B1 subtypes

Angela Stufano, Mariangela Pizzo, Simona De Grazia, Francesca Dapporto, Maria Alfreda Stincarelli, Carolina Bonifazi, Claudia Maria Trombetta, Roberta Antonelli, Pietro Piu, Ginevra Giglioli, Alessandro Manenti, Giulia Riolo, Emanuele Montomoli, Piero Lovreglio, Giulia Roscia, Noemi Guerrini, Valentina Biagini
article en
2 citations

Abstract

Since 2001, human Metapneumovirus has been a significant cause of human respiratory disease worldwide, and no vaccine or preventive treatment is currently available. The ELISA-based live virus microneutralization assay is a method to detect neutralizing antibodies against a target pathogen. The aim of this study was to demonstrate the suitability of this approach to quantifying neutralizing antibodies against A1 and B1 virus subtypes in human serum samples. To standardize and validate this microneutralization assay, we carried out analytical procedures according to the International Council of Harmonization guidelines; these procedures are described in detail. In addition, we compared the validated method with the indirect ELISA, and confirmed that the ELISA-based microneutralization assay provides reliable, accurate and reproducible results. The use of this high-throughput method for large-scale serological studies could effectively support the evaluation of the immunogenicity of new vaccines, thereby improving therapeutical strategies against human Metapneumovirus.

Scientific ReportsVol. 15(1)
University of Siena (IT), VisMederi Research (IT), University of Bari Aldo Moro (IT), University of Palermo (IT)
Erasmus Medisch Centrum
Good health and well-being
Openalex Percentile: Top 11%
Respiratory viral infections research
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.